Belgium’s infection control market is projected to grow at a compound annual growth rate of 6.18% over the forecast period to attain a market size of US$276.375 million in 2027, from US$181.664 million in 2020.
One of the most common reasons for the spread of diseases is improper compliance in regard to the safety and preventive measures that must be taken, such as proper washing of hands, sterilizing instruments, disinfecting the patient’s surroundings with techniques such as sterilizing machines, hand sanitisers, alcohol-based floors, and surrounding cleaners, among others. Thus, it has led to an increase in the demand for such solutions and is providing a boost to the market’s growth and is going to do so over the forecast period.
Moreover, there are guidelines in place by the Institut Scientifique de Sante Publique, Belgium, that lay down rules, indicators, and guidelines that must be followed to prevent and control the spread of diseases in Belgian hospitals. According to the report and guidelines, HAI, also known as Hospital Acquired Infections, pose a serious problem and are attributable to around 37,000 deaths in European countries (according to the ECDC). One of the most major and common guidelines, which is not practised, is following proper hand hygiene, and there are five conditions and moments during which it must be given utmost importance. These include, before making contact with the patient, and before an aseptic task has to be performed after the healthcare professional or worker has been subjected to or been in close contact with bodily fluids. The other moments include after-patient contact and contact with the patient's surroundings. In addition to this, each hospital and medical service institution is provided with a dedicated budget to solve the problems related to infection prevention and control.
In conjunction, the Belgian Infection Control Society (BICS) is a scientific society that represents the healthcare workers and individuals who are involved in services and solutions related to infection control and prevention. The primary goal of this group is to advance knowledge and proficiency in the field of proper and effective detecting procedures to be employed throughout the care of patients.
Furthermore, the market payers show interest in providing the population with innovative and advanced products. For example, STERIS, a company based in Ireland and one of the leaders in providing infection prevention and control solutions, offers different products as a part of its portfolio. Under its product category of "Prolystica Ultra Concentrate Cleaning Chemistries," which is a product that has been specially designed for surgical instrument cleaning, If provides two separate products designed for the use of automated washing and disinfectant machines for surgical instruments and to provide the high-performance formulation to deliver a low-foam environment. It also offers a product for manual cleaning called the "Prolystica 2X Concentrate Cleaning Chemistries," among other products.
COVID-19 SCENARIO
The COVID-19 pandemic had a favourable effect on the market for infection prevention. The demand for infection control goods like hand sanitisers and surgical masks increased as the number of COVID-19-infected cases increased globally, impacting the healthcare industry and other industries. The abrupt coronavirus outbreak caused a jump in demand for infection control supplies. The outbreak increased the emphasis on research and development activities in the pharmaceutical industry and the life sciences. To maintain the products, research tools, and overall research environment safe and free from contamination, the demand for infection control products increased as a result of the overall increase in research activity. Given the mutant COVID-19 variations and ongoing initiatives by both public and commercial entities to stop the disease's transmission, demand for infection control solutions will keep increasing in the upcoming years.
Segmentation